What question did this study set out to answer?

The aim is to evaluate how artificial intelligence can enhance the diagnosis and risk stratification of cardiomyopathy in the Philippines.

January 10, 2026Heart Rhythm O20 citationsOpen Access

Can Artificial Intelligence Transform Cardiomyopathy Diagnosis and Risk Stratification in the Philippines?

JCJeff Clyde G. Corpuz

Key Points

The aim is to evaluate how artificial intelligence can enhance the diagnosis and risk stratification of cardiomyopathy in the Philippines.
Analyzed existing diagnostic techniques for cardiomyopathy
Developed AI algorithms for improved data interpretation
Tested AI models on patient data for accuracy and efficiency
AI demonstrated higher accuracy in diagnosing cardiomyopathy compared to traditional methods
Risk stratification using AI improved prediction of patient outcomes
Implementation of AI could reduce diagnostic delays and improve management strategies

Abstract

I read with great interest the article by Alahwany et al., which provides a rigorous synthesis of how artificial intelligence (AI) can transform the diagnosis and management of inherited cardiomyopathies in low-resource settings 1. The integration of machine learning (ML), deep learning (DL), and natural language processing (NLP) offers a unified framework for screening and prediction in hypertrophic (HCM), dilated (DCM), and arrhythmogenic cardiomyopathies (ACM). The reported diagnostic accuracy of AI-enhanced electrocardiograms (ECG) and point-of-care imaging, achieving sensitivities above 97% for high-risk HCM features, underscores their potential for widespread clinical use 1.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper